Lethira

Lethira

levetiracetam

Manufacturer:

Pharos
Concise Prescribing Info
Contents
Levetiracetam
Indications/Uses
Adjunctive treatment of partial onset of seizure w/ or w/o secondary generalisation in patient w/ epilepsy.
Dosage/Direction for Use
Adult & childn ≥16 yr Initially 500 mg 2 times daily, may increase up to 1,500 mg 2 times daily. Dose change can be made in 500 mg 2 times daily increments or decrements 2-4 wkly. Daily dose is administered in 2 equally divided doses.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to pyrrolidones.
Special Precautions
Abrupt discontinuation, renal impairment, severe hepatic impairment. May affect ability to drive or operate machinery. Pregnancy & lactation. Elderly.
Adverse Reactions
Asthenia, somnolence, amnesia, ataxia, convulsion, headache, dizziness, depression, emotional liability, hostility, insomnia, nervousness; diarrhoea, dyspepsia, nausea; anorexia; vertigo; diplopia; accidental injury; rash.
MIMS Class
Anticonvulsants
ATC Classification
N03AX14 - levetiracetam ; Belongs to the class of other antiepileptics.
Presentation/Packing
Form
Lethira FC tab 250 mg
Packing/Price
30's (Rp120,000/boks)
Form
Lethira FC tab 500 mg
Packing/Price
20's (Rp140,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in